Both in Surgical Instruments
Boston Scientific vs Stryker
Over the past year BSX returned −57.4% and SYK returned −18.5%; their daily moves had a correlation of 0.41.
BSX −57.4% SYK −18.5%Growth of $1, one year, split-adjusted
| Metric | BSX | SYK |
|---|---|---|
| Price | $41.98 | $291.86 |
| Market cap | $60.84B | $111.95B |
| Today | −1.66% | −6.38% |
| 1 month | −2.9% | +6.9% |
| 6 months | −25.7% | −1.0% |
| Year to date | −56.0% | −17.0% |
| 1 year | −58.1% | −21.0% |
| Revenue growth (YoY) | +7.5% | +7.6% |
| Gross margin | 70.7% | 65.2% |
| Net margin | 16.7% | 11.5% |
| P/E (TTM) | 16.6× | 30.9× |
| Price / sales | 2.9× | 4.3× |
| Net cash | -$12.09B | -$11.66B |
| Dividend yield | — | 1.21% |
| Volatility (60d) | 34.7% | 34.7% |
| Short % of float | 2.8% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).